التفاصيل البيبلوغرافية
| العنوان: |
Genetic polymorphism of is associated with poor response to ifosfamide treatment in children with solid embryonic tumors. |
| المؤلفون: |
Torres Espindola, Luz María, De JesÚs Castillejos López, Manuel, De Uña Flores, Armando, Rivera Espinosa, Liliana Rivera, Granados, Julio, Chávez Pacheco, Juan Luis, Pérez García, Martín, Ramos Cervantes, Ma Teresa, Bekker Méndez, Vilma Carolina, Hernández Doño, Susana, Ruíz Gómez, Daniela, Espindola, Luz María Torres, López, Manuel De JesÚs Castillejos, Flores, Armando De Uña, Espinosa, Liliana Rivera, Pacheco, Juan Luis Chávez, García, Martín Pérez, Cervantes, Ma Teresa Ramos, Méndez, Vilma Carolina Bekker, Doño, Susana Hernández |
| المصدر: |
Archives of Medical Science; 2021, Vol. 17 Issue 6, p1766-1771, 6p |
| مصطلحات موضوعية: |
GENETIC polymorphisms, CYTOCHROME P-450 CYP3A, IFOSFAMIDE, SINGLE nucleotide polymorphisms, GENETIC variation |
| مستخلص: |
Introduction: The CYP450 complex participates in the metabolism of ifosfamide, an antineoplastic drug used to treat solid tumors. CYP450 genes contain several single nucleotide polymorphisms (SNPs) that confer different activity towards the enzyme. The aim of our study was to analyze gene frequencies of allelic variants and their association with ifosfamide blood levels and patient prognosis.Material and Methods: 148 DNA samples from children were analyzed. Genotyping was performed by real-time PCR with TaqMan probes and ifosfamide levels were determined in dried blood drop by UPLCMS/MS.Results: Ifosfamide levels increased according to the genotype, and patients with the variant rs1799853 in CYP2C9 genotype CC had lower levels of ifosfamide (median = 1.8 μmol/l, Q25 0.9-Q75 4.6) compared with patients with genotype TT + CT (median = 2.8 μmol/l, Q25 1.9-Q75 5.1), p < 0.001. In the case of the rs2740574 variant in the CYP3A4 gene, patients with normal genotype (TT) presented median = 1.4 μmol/l, (Q25 0.7-Q75 2.7), while patients with the CC + TC genotype had higher levels of ifosfamide (median = 2.0 μmol/l, Q25 1.0-Q75 4.3), p = 0.024. In addition, patients with CC + CT genotype of this variant had a higher risk of non-response to treatment compared to patients with TT genotype (RR = 1.3, 95% CI: 1.07-1.59, p = 0.03).Conclusions: Polymorphisms in CYP2C9 and CYP3A4 genes are associated with high levels of ifosfamide. In addition, the polymorphism rs2740574 in CYP3A4 was associated with a worse therapeutic response. [ABSTRACT FROM AUTHOR] |
|
Copyright of Archives of Medical Science is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder